(MedPage Today) — Daily lithium carbonate showed a promising signal in the pilot LATTICE trial of older adults with mild cognitive impairment, but failed to meet a prespecified significance threshold for any of six coprimary outcomes compared…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
